Inmar Expands Pharma Returns Capabilities In Canada
Inmar, the leading pharmaceutical returns provider in North America, today announced the company's move to a larger facility in the Greater Toronto area, increasing the company's capability for processing returns for manufacturers, retailers and wholesalers across Canada.
The new 45,000 square-foot facility accommodates Inmar's growth plans and increases capacity for the efficient, compliant processing of prescription pharmaceuticals, NCD (narcotics and controlled drugs) and OTC medications, as well as consumer goods.
"This expansion is an exciting step for Inmar, as it positions us to handle an even greater volume of returns and recalls in an efficient and timely manner," said John Waller, Director, Business Development, Inmar.
Waller said the larger Toronto facility also means expanding staffing in the areas of customer service and operations, increasing general customer service capacity and continuing the top-notch assistance that clients have come to expect from Inmar.
Operating in the new Toronto location since November 2015, the facility was specifically designed to accommodate Inmar's superior processing and technology, while expanding to meet market demand for efficient, cost-effective, compliant reverse-logistics processing.
Inmar is a technology company that operates intelligent commerce networks. Our platforms connect offline and online transactions in real time for leading retailers, manufacturers and trading partners across multiple industries who rely on Inmar to securely manage billions of dollars in transactions. Our Promotions, Supply Chain and Healthcare platforms enable commerce, generate meaningful data and offer growth-minded leaders actionable analytics and execution with real-time visibility. Founded in 1980, Inmar is headquartered in Winston-Salem, North Carolina with locations throughout the United States, Mexico and Canada.